1. Patient maintains baseline liver function during drug therapy. • Patient returns for follow-up care for monitoring of lipid levels and for adverse effects. 2. Patient demonstrates knowledge of the...

1. Patient maintains baseline liver function during drug therapy.

• Patient returns for follow-up care for monitoring of lipid levels and for adverse effects.

2. Patient demonstrates knowledge of the risk for liver dysfunction associated with antilipemic therapy. • Patient states the conditions that may arise of which the prescriber must be notified, such as jaundice and abdominal pain. • Patient states the importance of follow-up care with the prescriber to monitor for changes in liver function and monitoring of liver function tests.